Join the Tuberculosis group to help and get support from people like you.
Tuberculosis News
Related terms: TB
Persistent Disparities Seen by Race/Ethnicity in Incidence of TB
TUESDAY, April 2, 2024 – Persistent disparities by race/ethnicity are seen in the incidence of tuberculosis (TB), according to a study published online April 2 in the Annals of Internal Medicine....
CDC: Tuberculosis Case Counts, Rates Increasing Since 2020
MONDAY, April 1, 2024 – Tuberculosis (TB) case counts and rates have been increasing since 2020, according to research published in the March 28 issue of the U.S. Centers for Disease Control and...
U.S. TB Cases Reach Highest Level in a Decade
FRIDAY, March 29, 2024 – Tuberculosis cases are on the rise in the United States, with the number of reported infections in 2023 the highest seen in a decade. Forty states logged an increase in ...
U.S. Safety Protocols Stopped TB in Imported Lab Monkeys From Spreading to Humans
THURSDAY, Feb. 22, 2024 – Rigorous safety protocols prevented an outbreak of tuberculosis last year in lab monkeys imported to the United States from spreading to humans, a new report shows....
Dexamethasone No Benefit in HIV-Positive With Tuberculous Meningitis
THURSDAY, Oct. 12, 2023 – For HIV-positive adults with tuberculous meningitis, adjunctive dexamethasone does not confer a benefit with respect to survival, according to a study published in the Oct....
FDA Approves New Pediatric Formulation of Sirturo (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidrug-Resistant Tuberculosis
NEW BRUNSWICK, NJ, May 27, 2020 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric f...
FDA Approves Pretomanid for Highly Drug-Resistant Forms of Tuberculosis
NEW YORK August 14, 2019 - Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the...
FDA Approves Sirturo to Treat Multi-Drug Resistant Tuberculosis
December 31, 2012 – On Dec. 28, the U.S. Food and Drug Administration approved Sirturo (bedaquiline) as part of combination therapy to treat adults with multi-drug resistant pulmonary tuberculosis...
Ask a question
To post your own question to this support group, sign in or create an account.